MX2010003511A - Método optimizado y definido para el aislamiento y conservación de células precursoras del cordón umbilical humano. - Google Patents

Método optimizado y definido para el aislamiento y conservación de células precursoras del cordón umbilical humano.

Info

Publication number
MX2010003511A
MX2010003511A MX2010003511A MX2010003511A MX2010003511A MX 2010003511 A MX2010003511 A MX 2010003511A MX 2010003511 A MX2010003511 A MX 2010003511A MX 2010003511 A MX2010003511 A MX 2010003511A MX 2010003511 A MX2010003511 A MX 2010003511A
Authority
MX
Mexico
Prior art keywords
cells
umbilical cord
optimized
isolation
precursor cells
Prior art date
Application number
MX2010003511A
Other languages
English (en)
Spanish (es)
Inventor
Rita Isabel Ganchas Soares
Maria Constanca Baptista Coelho
Jorge Miguel Silva Santos
Pedro Estilita Da Cruz
Jose Paulo Martins
Vera Alexandra Basto
Helder Joaquim Soares Da Cruz
Original Assignee
Medinfar Produtos Farmaceutico
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medinfar Produtos Farmaceutico filed Critical Medinfar Produtos Farmaceutico
Publication of MX2010003511A publication Critical patent/MX2010003511A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0604—Whole embryos; Culture medium therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pregnancy & Childbirth (AREA)
  • Rheumatology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
MX2010003511A 2007-10-04 2008-10-03 Método optimizado y definido para el aislamiento y conservación de células precursoras del cordón umbilical humano. MX2010003511A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PT103843A PT103843B (pt) 2007-10-04 2007-10-04 Método de isolamento de células precursoras a partir do cordão umbilical humano
PCT/IB2008/054067 WO2009044379A2 (en) 2007-10-04 2008-10-03 Optimised and defined method for isolation and preservation of precursor cells from human umbilical cord

Publications (1)

Publication Number Publication Date
MX2010003511A true MX2010003511A (es) 2010-09-10

Family

ID=40456372

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010003511A MX2010003511A (es) 2007-10-04 2008-10-03 Método optimizado y definido para el aislamiento y conservación de células precursoras del cordón umbilical humano.

Country Status (15)

Country Link
US (1) US9546353B2 (enExample)
EP (1) EP2203555B1 (enExample)
JP (1) JP5785394B2 (enExample)
KR (1) KR20100087705A (enExample)
CN (1) CN101868536B (enExample)
AU (1) AU2008306442B2 (enExample)
BR (1) BRPI0817522A2 (enExample)
CA (1) CA2701907A1 (enExample)
EA (1) EA025532B1 (enExample)
ES (1) ES2582369T3 (enExample)
IL (1) IL204788A (enExample)
MX (1) MX2010003511A (enExample)
PT (1) PT103843B (enExample)
WO (1) WO2009044379A2 (enExample)
ZA (1) ZA201002260B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011153205A1 (en) 2010-06-01 2011-12-08 Auxocell Laboratories, Inc. Native wharton's jelly stem cells and their purification
SG189414A1 (en) 2010-10-18 2013-05-31 Sunshine Biotech Inc Human multipotent embryonic stem cell-like progenitor cells
TWI535377B (zh) * 2011-09-01 2016-06-01 Storage, culture and application of umbilical cord tissue and its derived cells
PL3321355T3 (pl) 2011-12-30 2021-12-27 Amit Patel Sposoby i kompozycje do klinicznego pozyskiwania komórek alogenicznych oraz zastosowania terapeutyczne
CN102550543B (zh) * 2012-02-10 2014-04-16 四川新生命干细胞科技股份有限公司 用于保存脐带组织的液体
CN103461322B (zh) * 2012-06-07 2016-08-03 西比曼生物科技（上海）有限公司 用于冻存复苏后的细胞的保存液
EP2756754B1 (de) 2013-01-17 2017-01-04 Vita 34 Ag Verfahren zur Behandlung von Nabelschnurgewebe, insbesondere im Zusammenhang mit der Konservierung des Gewebes
EP3149157A4 (en) * 2014-05-24 2018-06-13 Neelamkrishnan Venkataramanaa A method for targettingglioblastoma with wharton jelly-mesenchymal stem cells (wj-msc) derived from human umbilical cord
CN107073044A (zh) * 2014-11-05 2017-08-18 组织技术公司 用于促进神经生长及再生的组合物和方法
WO2017004460A1 (en) * 2015-06-30 2017-01-05 Surgenex, LLC Compositions and methods for flowable allograft tissue
US11254915B2 (en) * 2015-12-11 2022-02-22 Lei Guo Method for separating and culturing mesenchymal stem cells from Wharton's jelly tissue of umbilical cord
WO2019175773A1 (en) 2018-03-12 2019-09-19 Universidade Do Porto Compositions for use in the treatment of musculoskeletal conditions and methods for producing the same leveraging the synergistic activity of two different types of mesenchymal stromal/stem cells
CN112342191A (zh) * 2019-08-07 2021-02-09 路春光 hMSC生产试剂盒开发和质量管理标准优化和体系建立
CN111893092A (zh) * 2020-06-28 2020-11-06 国大生命科学产业集团(深圳)有限公司 一种人脐带来源的间充质干细胞及其制备方法
CN113025567A (zh) * 2021-03-31 2021-06-25 中国人民解放军陆军特色医学中心 一种椎间盘单细胞的分离方法
DE102021116694B4 (de) * 2021-06-29 2023-03-09 Promocell Gmbh Wässrige Lösung zur Zellkonservierung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT402890B (de) * 1994-03-16 1997-09-25 Berbi Gmbh Verwendung von notoginsenosid r1 zur herstellung von arzneimitteln
AU2003221173A1 (en) * 2002-03-27 2003-10-08 Asahi Kasei Kabushiki Kaisha Placenta-origin mesenchymal cells and medicinal use thereof
AU2006332680A1 (en) * 2005-12-29 2007-07-12 Anthrogenesis Corporation Improved composition for collecting and preserving placental stem cells and methods of using the composition
ES2524443T3 (es) * 2006-11-13 2014-12-09 DePuy Synthes Products, LLC Expansión in vitro de células postparto usando microportadores

Also Published As

Publication number Publication date
EA025532B1 (ru) 2017-01-30
US9546353B2 (en) 2017-01-17
JP2010539970A (ja) 2010-12-24
KR20100087705A (ko) 2010-08-05
PT103843B (pt) 2008-08-12
CA2701907A1 (en) 2009-04-09
IL204788A (en) 2013-07-31
JP5785394B2 (ja) 2015-09-30
BRPI0817522A2 (pt) 2014-10-14
US20100216237A1 (en) 2010-08-26
ZA201002260B (en) 2011-06-29
WO2009044379A2 (en) 2009-04-09
CN101868536A (zh) 2010-10-20
EP2203555A2 (en) 2010-07-07
AU2008306442A1 (en) 2009-04-09
ES2582369T3 (es) 2016-09-12
CN101868536B (zh) 2015-03-25
EP2203555B1 (en) 2016-04-13
PT103843A (pt) 2008-01-09
WO2009044379A3 (en) 2009-05-22
IL204788A0 (en) 2010-12-30
AU2008306442B2 (en) 2014-12-04
EA201000425A1 (ru) 2010-10-29

Similar Documents

Publication Publication Date Title
WO2009044379A3 (en) Optimised and defined method for isolation and preservation of precursor cells from human umbilical cord
Kong et al. Cardiac fibrotic remodeling on a chip with dynamic mechanical stimulation
Neri et al. Molecular mechanisms contributing to mesenchymal stromal cell aging
Yoon et al. Thermosensitive, stretchable, and piezoelectric substrate for generation of myogenic cell sheet fragments from human mesenchymal stem cells for skeletal muscle regeneration
ES2544967T3 (es) Formulación y método para la prevención y el tratamiento de las metástasis óseas o de otras enfermedades óseas
Jian et al. Bioinspired self‐growing hydrogels by harnessing interfacial polymerization
BRPI0817911B8 (pt) Processos para transferência de substâncias moleculares para dentro de células vegetais e processo para expressão de um gene
WO2008073635A3 (en) Automatable artificial immune system (ais)
EP3190180A3 (en) A method for identifying, expanding, and removing adult stem cells and cancer stem cells
SV2011003888A (es) Compuestos que expanden las celulas madre hematopoieticas
NZ593364A (en) Pharmaceutical preparation comprising supernatant of blood mononuclear cell culture
HK1203219A1 (en) Method of treatment employing therapeutic t cell product from mobilised donors
WO2014186469A3 (en) Human application of engineered chimeric antigen receptor (car) t-cells
WO2012048093A3 (en) Enhanced msc preparations
BR112012021267A2 (pt) métodos para a preparação de melanócitos a partir de células tronco humanas pluripotentes.
MX2018010529A (es) Composiciones y metodos para la produccion y administracion de acido ribonucleico.
EA201170635A1 (ru) Композиции, способы получения и применение каркаса на основе домена фибронектина типа iii
BRPI0620946A8 (pt) anticorpo il-23p19 isolado, composição, método in vitro, artigo de fabricação, molécula e vetor de ácido nucleico, célula hospedeira procariótica
CY1110860T1 (el) Αναστροφη μεταγραφαση τελομερασης πτηνου
NZ630598A (en) Method of engrafting cells from solid tissues
NZ593365A (en) Pharmaceutical preparation comprising a blood mononuclear cell culture
CL2007003357A1 (es) Anticuerpo o fragmento funcional del mismo capaz de inhibir la proliferacion de celulas tumorales in vitro y/o in vivo; acido nucleico que lo codifica; metodo de produccion; composicion que lo comprende; y su uso para tratar el cancer.
PL1863905T3 (pl) Sposób aktywacji naturalnych komórek zabójców preparatami komórek guza in vitro
CO6761392A2 (es) Administración de proteínas a partir de microportadores de células madre
WO2010032008A3 (en) Dendritic cell modulatory molecule

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration